novartis ag-reg (NOVN:SIX Swiss Ex)
Executive Profile*
Ann M. FudgeDirector, Member of Corporate Governance & Nomination Committee and Member of Risk Committee, Novartis AG |
| Age | Total Calculated Compensation | This person is connected to 481 board members in 17 different organizations across 20 different industries. See Board Relationships |
| 61 | $450,038 |
Background*
Ms. Ann M. Fudge serves as the Head of the Y&R network at Young & Rubicam Inc. Ms. Fudge served as the Chairman and Chief Executive Officer of Young & Rubicam Brands of WPP Plc. She served as the Chairman of Y&R Advertising, Inc. until 2011 and served as its Chief Executive Officer. She joined General Foods USA in 1986 and held several planning and marketing positions before being appointed as Executive Vice President and General Manager of the Dinners and Enhancers ...
Corporate Headquarters*Lichtstrasse 35Basel, Basel-Stadt 4056 Switzerland Phone: 41 61 324 11 11 Fax: 41 61 324 80 01 Board Members Memberships*Former Director Trustee Director Trustee Former Vice Chairman and Member of Board of Governors Director Director Director Honorary Director Director 1993-2003 Former Director 1999-Present Independent Director and Member of Public Responsibilities Committee 1999-Present Independent Director of General Electric Company 2001-2003 Former Director 2008-Present Director, Member of Corporate Governance & Nomination Committee and Member of Risk Committee 2009-Present Non-Executive Director, Member of Compensation & Management Resources Committee and Member of Nominating & Corporate Governance Committee 2009-Present Non-Executive Director, Member of Compensation & Management Resources Committee and Member of Nominating & Corporate Governance Committee 2009-Present Non-Executive Director 2011-Present Independent Director, Chairperson of Management Development & Compensation Committee and Member of Nominations & Governance Committee
Education*MBA 1977 Harvard University BA 1973 Simmons College
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| NOVN:VX | SFr.71.45 CHF | -2.20 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Paul Bulcke | Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee Nestlé S.A. | SFr.6.2M |
| Robert A. McDonald | Chairman, Chief Executive Officer, President and Member of Proxy Committee Procter & Gamble Co. | $4.0M |
| Alex Gorsky | Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee Johnson & Johnson | $1.1M |
| Ian C. Read | Chairman, Chief Executive Officer and Chairman of Executive Committee Pfizer Inc. | $1.7M |
| Severin Schwan | Chief Executive Officer and Director Roche Holding AG | SFr.6.5M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Miami, FL | Noven PharmaceuticalsPosted: May 06
- Miami, FL | Noven PharmaceuticalsPosted: May 01
- Miami, FL | Noven PharmaceuticalsPosted: Apr 28
- New York, NY | Noven PharmaceuticalsPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








